TearCare System
Evaporative Dry Eye Disease (Meibomian Gland Dysfunction)
Key Facts
About Sight Sciences
Sight Sciences is a publicly traded medical technology company focused on addressing significant unmet needs in glaucoma and dry eye disease through proprietary, minimally invasive device platforms. The company has achieved commercial success with its OMNI Surgical System for glaucoma and TearCare System for dry eye, both of which are designed to integrate into existing clinical workflows. Its strategy centers on leveraging clinical data to drive adoption, expanding indications for its core technologies, and penetrating large, growing global ophthalmic markets. Despite commercial traction, the company faces challenges including reimbursement dynamics, competitive pressure, and the need to demonstrate long-term cost-effectiveness.
View full company profile